TGF- β1 is one of neurotrophic agents which induces neuroprotective action opposing β-amyloid-induced neurodegeneration where mal signaling of TGF-β1 is believed to be involved in early stages in the pathogenesis of AD (Bosco et al., 2013). This evidence concerns the gene TGFB1 and Alzheimer disease.